| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 120.71B | 128.20B | 119.15B | 102.66B | 108.81B | 94.58B |
| Gross Profit | 32.62B | 36.96B | 33.58B | 26.96B | 28.69B | 22.68B |
| EBITDA | 19.87B | 22.82B | 19.93B | 13.93B | 14.18B | 11.25B |
| Net Income | 11.95B | 14.50B | 12.10B | 7.51B | 8.10B | 5.59B |
Balance Sheet | ||||||
| Total Assets | 133.36B | 158.74B | 138.53B | 138.86B | 129.34B | 118.68B |
| Cash, Cash Equivalents and Short-Term Investments | 8.99B | 11.62B | 10.22B | 9.57B | 9.49B | 8.73B |
| Total Debt | 15.06B | 12.59B | 14.96B | 21.82B | 22.03B | 21.86B |
| Total Liabilities | 54.33B | 59.83B | 58.40B | 64.41B | 66.72B | 64.59B |
| Stockholders Equity | 79.03B | 98.91B | 80.13B | 74.45B | 62.61B | 54.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.61B | 8.40B | 3.11B | 2.23B | 1.57B |
| Operating Cash Flow | 0.00 | 12.91B | 11.37B | 9.84B | 6.03B | 2.95B |
| Investing Cash Flow | 0.00 | -6.47B | -1.92B | -7.50B | -4.06B | -1.85B |
| Financing Cash Flow | 0.00 | -5.65B | -8.96B | -2.36B | -1.28B | -4.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥457.50B | 32.33 | ― | 1.01% | 7.59% | 19.82% | |
74 Outperform | ¥631.54B | 35.76 | 5.25% | 2.13% | -7.11% | 68.57% | |
72 Outperform | ¥520.03B | 39.52 | ― | 2.50% | 1.45% | 0.37% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥401.16B | 31.29 | ― | 1.65% | 5.02% | 19.84% | |
56 Neutral | ¥863.01B | -13.33 | 1.88% | 6.16% | 1.98% | -48.28% | |
55 Neutral | ¥747.96B | 456.64 | 5.94% | 0.56% | 7.03% | -53.53% |